Our mission on drug discovery and pharma research
MEDINA is leader in Drug Discovery from Microbial Natural Product Libraries and internal High Throughput Screening (HTS) programs are focused on strategic therapeutic areas: Infectious and Parasitic Diseases, Oncology and Neurodegeneration.
We are partners in European research networks and consortia in diverse areas of drug discovery and applied biotechnology.
MEDINA offers Contract Research services for Drug Discovery and other high value biotechnology areas to academic research and industrial organizations.
MEDINA discovers bio-active molecules, drug leads for unmet medical needs and high value biotechnological products.
We are exclusive owners of one of the world´s largest Microbial Collections (190,000 microbial strains), and Natural Products Libraries (over 135,000 extracts & fractions).
For more information about our data processing policy, please click here.
Latest news
Dr. Freddie Annang, specialist in parasitic diseases, attended the 12th Convention of Biomedical Research of Ghana from the 30th of July to the 1st of August to discuss Fundación MEDINA’s microbial library, infrastructure and professional expertise for possible...
Dr. Olga Genilloud, Scientific Director of Fundación MEDINA, attended the new Gordon Conference on Natural Products and Bioactive Compounds at the Proctor Academy in Andover, New Hampshire. She contributed to the session on Discovery and Chemistry of new Secondary...
Dr. Fernando Reyes, Head of Chemistry at MEDINA, and Dr. Mercedes Pérez Bonilla, Post-doctoral Researcher of the same department attended the Natural Products in Drug Discovery and Human health PSE Meeting celebrated in Lisbon from the 28th to the 31st of July....